Header Logo

Kimberly Lenz

Concepts (82)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
349
0.730
 Why?
Analgesics, Opioid
4
2019
499
0.610
 Why?
Pain
3
2019
406
0.580
 Why?
Medication Therapy Management
3
2018
25
0.400
 Why?
Antiviral Agents
3
2018
317
0.340
 Why?
Practice Patterns, Physicians'
5
2019
716
0.320
 Why?
Hepatitis C
2
2016
140
0.230
 Why?
United States
10
2019
7570
0.180
 Why?
Drug Utilization Review
2
2017
56
0.170
 Why?
Chloride Channel Agonists
1
2019
3
0.170
 Why?
Aminophenols
1
2019
4
0.170
 Why?
Drug and Narcotic Control
2
2017
30
0.170
 Why?
Benzodioxoles
1
2019
13
0.170
 Why?
Aminopyridines
1
2019
23
0.170
 Why?
Quinolones
1
2019
27
0.160
 Why?
Cystic Fibrosis
1
2019
108
0.150
 Why?
Uridine Monophosphate
1
2018
8
0.150
 Why?
Fluorenes
1
2018
13
0.150
 Why?
Medication Adherence
2
2017
254
0.150
 Why?
Benzimidazoles
1
2018
59
0.150
 Why?
Psychotropic Drugs
1
2018
83
0.140
 Why?
Insurance, Pharmaceutical Services
2
2014
24
0.140
 Why?
Hydrocodone
1
2017
6
0.140
 Why?
Hepatitis C, Chronic
1
2018
88
0.140
 Why?
Opioid-Related Disorders
2
2014
469
0.140
 Why?
Hepacivirus
1
2018
140
0.140
 Why?
Progesterone
1
2017
157
0.140
 Why?
Drug Prescriptions
1
2018
190
0.140
 Why?
Premature Birth
1
2017
108
0.130
 Why?
Lung
1
2019
838
0.120
 Why?
Prescription Drug Diversion
1
2014
7
0.120
 Why?
State Government
1
2014
32
0.110
 Why?
Prescription Drug Misuse
1
2014
22
0.110
 Why?
Drug Combinations
3
2019
137
0.110
 Why?
Drug Interactions
1
2014
113
0.110
 Why?
Managed Care Programs
1
2014
94
0.110
 Why?
Retrospective Studies
7
2018
6040
0.110
 Why?
Health Services Accessibility
1
2016
543
0.090
 Why?
Mental Disorders
1
2018
768
0.090
 Why?
Treatment Outcome
3
2016
5205
0.080
 Why?
Young Adult
4
2019
4365
0.080
 Why?
Adolescent
4
2019
5939
0.070
 Why?
Adult
6
2019
15882
0.070
 Why?
Humans
10
2019
59816
0.070
 Why?
Drug Costs
2
2016
59
0.060
 Why?
Cost Savings
2
2016
56
0.060
 Why?
Female
7
2019
31098
0.060
 Why?
Cost-Benefit Analysis
2
2017
301
0.060
 Why?
Middle Aged
5
2019
16401
0.060
 Why?
Pharmacists
2
2016
124
0.060
 Why?
Program Evaluation
2
2018
487
0.060
 Why?
Male
6
2019
27769
0.050
 Why?
Massachusetts
2
2018
2112
0.050
 Why?
Cohort Studies
2
2017
2461
0.040
 Why?
Child
2
2019
4324
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
75
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Sofosbuvir
1
2018
18
0.040
 Why?
Ribavirin
1
2018
24
0.040
 Why?
Polypharmacy
1
2018
62
0.040
 Why?
Treatment Failure
1
2018
189
0.040
 Why?
Hydroxyprogesterones
1
2017
6
0.040
 Why?
Controlled Substances
1
2017
5
0.040
 Why?
Viral Load
1
2018
229
0.040
 Why?
Dose-Response Relationship, Drug
1
2019
798
0.030
 Why?
Drug Therapy, Combination
1
2018
434
0.030
 Why?
RNA, Viral
1
2018
265
0.030
 Why?
Gestational Age
1
2017
184
0.030
 Why?
Psychiatry
1
2018
129
0.030
 Why?
Genotype
1
2018
641
0.030
 Why?
Insurance Claim Review
1
2016
80
0.030
 Why?
Evidence-Based Medicine
1
2018
454
0.030
 Why?
Pregnancy Outcome
1
2017
189
0.030
 Why?
Government Regulation
1
2014
44
0.030
 Why?
Interdisciplinary Communication
1
2014
107
0.030
 Why?
Physician's Role
1
2014
120
0.030
 Why?
Cooperative Behavior
1
2014
220
0.030
 Why?
Health Policy
1
2014
185
0.020
 Why?
Mutation
1
2019
2464
0.020
 Why?
Pregnancy
1
2017
2359
0.020
 Why?
Time Factors
1
2014
3590
0.020
 Why?
Aged
1
2018
13461
0.010
 Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_